News | April 26, 2012

SCAI Attendees Discuss Strategies to Reduce Costs, Eliminate Waste, Ensure Appropriate Use

April 26, 2012 — Interventional cardiologists can and should lead efforts to improve quality, cut costs and ensure appropriate use of procedures. Elliott Fisher, M.D., MPH, professor of medicine at Dartmouth, an internationally recognized expert on variations in health system performance and one of the originators of the concept of accountable care organizations, will challenge the interventional cardiology community to accomplish these and other goals at a town hall meeting during the 2012 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) in Las Vegas. His keynote address, “Why Interventional Cardiology Needs to be a Change Leader,” will set the stage for an interactive discussion with cardiologists attending the conference.

In his keynote address, Fisher will speak about the need for payment reform, the future of healthcare, why these changes are critical now and how interventional cardiologists can help lead the successful transformation of the U.S. healthcare system.

“Our health system simply cannot afford to continue the same patterns and models of care delivery that we have relied on in decades past,” said Fisher. “As physicians, we need to be leading the effort to put the systems in place that will result in both improved patient care and reduced costs. As a specialty, interventional cardiology has led the way in evidence-based care and quality improvement. I intend to deliver a message of challenge, hope and choice — and by that I mean, face up to our current fiscal predicament, realize this is a moment of opportunity and make the choice to fix it. If interventional cardiologists do this, they will be demonstrating to the larger healthcare community how these things can be done.”

An open discussion about the state of interventional cardiology will follow the keynote, featuring a panel of leading interventional cardiologists. Town hall faculty will share specific examples of how interventional cardiologists can continue their efforts to improve safety and quality through quality improvement initiatives, such as:

- Lessons from recent cases of alleged inappropriate and overuse of stenting in Maryland, presented by Mark Turco, M.D., FSCAI
- Cath lab accreditation to promote quality improvement in interventional cardiology, presented by Accreditation for Cardiovascular Excellence (ACE) Chief Medical Officer Bonnie Weiner, M.D., FSCAI
- SCAI’s Quality Improvement Toolkit (QIT), featuring guidelines and tools focused on peer-review conferences, random case selection, national database participation, pre-procedure checklists and other tools to aid in continuous quality improvement, presented by Jeffrey Marshall, M.D., FSCAI
- SCAI’s appropriate use criteria (AUC) smartphone application, providing interventional cardiologists easy access to relevant guidelines and the ability to instantaneously calculate “appropriateness,” presented by Kalon Ho, M.D., FSCAI

“Already the interventional cardiology community is leading important initiatives aimed at improving the quality of care. The vast majority of us are deeply committed to doing the right thing for our patients,” said SCAI 2012 program co-director Kenneth Rosenfield,
M.D., FSCAI. “Now we need all interventional cardiologists to join together in this mission. We have the opportunity to make a significant impact on cost and value in our profession and in the larger healthcare system.”

An interactive discussion with attendees will follow the presentations. The Town Hall session will take place Friday, May 11, 2012 from 11 a.m. to 12:45 p.m. (Pacific time).

For more information:

Related Content

Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
Overlay Init